Intrinsic Properties of Germinal Centre-derived B cells Promote their Enhanced Class Switching to IgE by Ramadani, Faruk et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
Intrinsic Properties of Germinal_RAMADNI_Published25October2015_GREEN SM
10.1111/all.12679
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Ramadani, F., Upton, N. E. G., Hobson, P. S., Chan, Y-C., Mzinza, D., Bowen, H., ... Gould, H. J. (2015).
Intrinsic Properties of Germinal Centre-derived B cells Promote their Enhanced Class Switching to IgE. Allergy,
70(10), 1269-1277. DOI: Intrinsic Properties of Germinal_RAMADNI_Published25October2015_GREEN SM,
10.1111/all.12679
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 28. Feb. 2018
ORIGINAL ARTICLE EXPERIMENTAL ALLERGY AND IMMUNOLOGY
Intrinsic properties of germinal center-derived B cells
promote their enhanced class switching to IgE
F. Ramadani1,3, N. Upton1,3, P. Hobson2,3, Y.-C. Chan1,3, D. Mzinza1,3, H. Bowen1,3,
C. Kerridge1,3, B. J. Sutton1,3, D. J. Fear2,3 & H. J. Gould1,3
1Randall Division of Cell and Molecular Biohphysics; 2Division of Asthma, Allergy and Lung Biology, King’s College London; 3Medical
Research Council and Asthma UK Centre, Allergic Mechanisms in Asthma, London, UK
To cite this article: Ramadani F, Upton N, Hobson P, Chan Y-C, Mzinza D, Bowen H, Kerridge C, Sutton BJ, Fear DJ, Gould HJ. Intrinsic properties of germinal
center-derived B cells promote their enhanced class switching to IgE. Allergy 2015; 70: 1269–1277.
Keywords
allergy; germinal center; human B cells; IgE
class switching.
Correspondence
Professor Hannah J. Gould, PhD or Faruk
Ramadani, PhD, Randall Division of Cell and
Molecular Biophysics, King’s College
London, New Hunt’s House, London
SE1 1UL, UK.
Tel.: +44(0)20-7848-6442
Fax: +44(0)20-7848-6435
E-mail: hannah.gould@kcl.ac.uk or
faruk.ramadani@kcl.ac.uk
Accepted for publication 18 June 2015
DOI:10.1111/all.12679
Edited by: Thomas Bieber
Abstract
Background: Research on the origins and development of human IgE-expressing
(IgE+) cells is required for understanding the pathogenesis of allergy and asthma.
These studies have been thwarted by the rarity of IgE+ cells in vivo and the low
frequency of class switch recombination (CSR) to IgE ex vivo. To determine the
main source of IgE+ cells, we investigated the relation between the phenotypic
composition of tonsil B cells and the CSR to IgE ex vivo.
Methods: Human tonsil B cells were analyzed by flow cytometry (FACS) and cul-
tured with IL-4 and anti-CD40 to induce CSR to IgE. Na€ıve, germinal center
(GC), early GC (eGC), and memory tonsil B cells were isolated by FACS, and
their capacities for IL-4 and anti-CD40 signaling, cell proliferation, and de novo
class switching to IgE were analyzed by RT-PCR and FACS.
Results: B cells from different tonsils exhibited varying capacities for CSR to IgE
ex vivo. This was correlated with the percentage of eGC B cells in the tonsil at
the outset of the culture. Despite relatively poor cell viability, eGC and GC B-cell
cultures produced the highest yields of IgE+ cells compared to na€ıve and memory
B-cell cultures. The main factors accounting for this result were the strength of
IL-4R and CD40 signaling and relative rates of cell proliferation.
Conclusions: This study shows that the maturation state of tonsil B cells determi-
nes their capacity to undergo class switching to IgE ex vivo, with the GC-derived
B cells yielding the highest percentage of IgE+ cells.
IgE provides immune defense against multicellular parasites
and venoms but also mediates adverse reactions to otherwise
harmless environmental antigens (allergens) in allergic dis-
ease and asthma (1, 2). The increasing prevalence of IgE-
mediated allergic disease is alarming. Yet very little is
known about the development of IgE+ cells (3) due to the
rarity of these cells in circulation and inaccessibility in
tissues (4).
Mature B cells develop from IgM+ B-cell precursors, gen-
erated in the bone marrow, and must undergo class switch
recombination (CSR) to express the ‘switched’ isotypes (IgG,
IgA, and IgE) (5, 6). CSR from IgM to another antibody
class requires recombination of the DNA sequence encoding
the expressed Ig heavy-chain variable region linked to the l
heavy-chain constant region (CH) with the CH of another
antibody class in the tandem array of CH germline genes in
the Ig heavy-chain locus (7, 8).
Most studies of B cells have used murine B cells and focused
on IgG, the most abundant antibody class in circulation
(10 000 more abundant than IgE) (4). CSR to IgG has been
shown to occur in secondary lymphoid tissue where antigen-ac-
tivated T helper (Th) cells interact with cognate B cells to stim-
ulate proliferation of the B cells and then form ‘GCs’ (9–11).
B-cell proliferation is engendered by the cognate interaction of
activated T cells (of one of two types, Th1 or Th2) with anti-
gen-specific B cells. The T cells provide a contact signal, CD40
ligand that binds to CD40 on the B cells, and secrete growth
factors (cytokines) that engender B-cell proliferation (9, 11,
12). The IgG1+ GC B cells undergo somatic hypermutation
(SHM) and selection (affinity maturation) to secrete high-affin-
ity antibodies (10, 11, 13, 14).
Recent studies in the mouse have overcome the difficulty
of detecting IgE+ cells in vivo using novel ultrasensitive
tracking methods, revealing dramatic differences between the
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development of IgG+ and IgE+ cells (15–18). The relevance
of the conclusions from these studies to the understanding of
allergic disease in humans nevertheless requires validation
(3). However, CSR to IgE occurs at a very low frequency
compared to IgG (4), hence the difficulty in following the
subsequent development of the human IgE+ cells (3).
Tonsils provide a readily accessible and abundant source
of human B cells from secondary lymphoid tissue. They con-
tain a heterogeneous mixture of B cells comprising several
different phenotypes, including na€ıve, eGC, GC, and memory
B cells and plasmablasts (19). These cells can be induced to
undergo CSR to IgE by stimulating with IL-4 and anti-CD40
ex vivo, mimicking the conditions required for CSR to IgE
in vivo. The IL-4 receptor (IL-4R) and CD40 signaling upreg-
ulate the expression of e germline gene transcripts (eGLTs)
and mRNA for the enzyme activation-induced cytidine deam-
inase (AID), two factors required for CSR to IgE (20–23).
Here, we observed a wide variation in the capacity of cul-
tured tonsil B cells, from different donors, to undergo CSR
to IgE ex vivo. We hypothesized that this variability could be
due to the variations in the phenotypic composition of stimu-
lated tonsil B cells at the outset of the culture. Indeed, here
we report a positive correlation between the proportion of
eGC B cells in the purified tonsil B cells at the outset of the
culture and the yields of IgE+ cells at the end of the cultures.
We then compared the capacity of various B-cell subsets to
undergo CSR to IgE and found that B cells from different
stages of development can be induced to undergo CSR to
IgE. However, the intrinsic properties, namely their enhanced
proliferation and IL-4R and CD40 signaling, of GC-derived
B cells make them much more efficient in CSR to IgE.
Methods
Isolation of human tonsil B cells
Following informed written consent, with ethical approval
from St Thomas and Guy’s Research Ethics Committee, we
obtained human tonsils from child donors undergoing rou-
tine tonsillectomies at the Evelina Children’s Hospital, St
Thomas’ Hospital, United Kingdom. We obtained verbal
information on the allergic status of the donor from patients
or carers at the time of consent. Mononuclear cells were sep-
arated by density centrifugation on a Ficoll gradient (GE
Healthcare, Buckinghamshire, UK) and B cells isolated using
2-aminoethylisothiouronium bromide-treated sheep RBCs
(TCS Biosciences Ltd, Buckingham, UK). B cells were >95%
CD19+ as determined by flow cytometry (FACS).
FACS analysis
Surface and intracellular staining of cells was performed as
previously described (24). For intracellular staining, cells
were fixed with 2% paraformaldehyde (Electron Microscopy
Sciences, Hatfield, USA), washed, and resuspended in perme-
abilization buffer (PBS, 0.5% Triton X-100, and 0.5% sapo-
nin) (Sigma-Aldrich Ltd, Dorset, UK) for 20 min at RT. The
cells were then washed with PBS + 5% goat serum and
stained with fluorescently labeled antibodies (see Table S1 for
the list of antibodies used) in the dark for 30 min. To deter-
mine the cell viability of the cultured cells, we used the live/
dead fixable dead stain kit (Life Technologies Ltd, Paisley,
United Kingdom). To measure the levels of phosphorylated
STAT6 and NFjB proteins in na€ıve, memory, eGC, and GC B
cells 24 h after culture with IL-4 and anti-CD40, cells were
fixed, permeabilized, and stained with rabbit anti-human p-
STAT-6 (Tyr641) and rabbit anti-human p-NFjB p65 (Ser536)
followed by goat anti-rabbit IgG F(ab’)2 APC. Data were col-
lected on a BD FACSCalibur or BD FACSCantoTM (BD Bio-
sciences, San Jose, CA, USA) and analyzed using FLOWJO
software version 7.6.3 (Tree Star Inc., Ashland, OR, USA).
Cell cultures
To induce CSR to IgE, B cells were cultured as previously
described (24). Briefly, freshly isolated tonsil B cells were cul-
tured at 0.5 9 106/ml in RPMI 1640 with penicillin (100 IU/
ml), streptomycin (100 lg/ml), glutamine (2 mM; Invitrogen),
10% FCS (Hyclone; Hyclone Laboratories, Inc. South
Logan, UT, USA), transferrin (35 lg/ml), and insulin (5 lg/
ml) (Sigma-Aldrich). B cells were stimulated with IL-4
(200 IU/ml; R&D Europe Systems Ltd, Abingdon, UK) and
anti-CD40 antibody (0.5 lg/ml; G28.5; American Type Cul-
ture Collection, Manassas, VA, USA) for up to 12 days.
Cell sorting
Tonsil B cells were surface-stained with anti-human
CD27 and anti-human CD38 on ice for 15–30 min and
then na€ıve (CD27CD38), eGC (CD27CD38+), GC
(CD27+CD38+/++), and memory (CD27+CD38) B cells
were isolated using a BD FACSAria 85 micron nozzle (BD
Bioscience). Sorted cells were checked for purity, counted,
and cultured with IL-4 and anti-CD40 antibody (as above).
Cell proliferation
Single-cell suspensions were labeled with 10 lM carboxyfluo-
rescein diacetate succinimidyl ester (CFSE) according to the
manufacturer’s instructions (CellTraceTM CFSE Cell Prolifer-
ation Kit; Life Technologies). After 12 days of incubation
with IL-4 and anti-CD40, cells were harvested and acquired
on a BD FACSCalibur (BD Biosciences).
ELISA
Secreted IgE and IgG in the supernatant of CSR cultures
were measured by ELISA as described previously (24), except
that 3,30,5,50-tetramethylbenzidine (TMB) substrate was used
to develop the color reaction (R&D Europe Systems Ltd)
and plates were read at 450 nm.
RNA isolation and quantitative RT-PCR
Total RNA was isolated from cells using the Qiagen
RNeasy Mini Kit with on-column DNase digestion (Qiagen
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Ltd, Manchester, UK) and reverse-transcribed with Max-
ima Reverse Transcriptase enzyme (Fermentas GmbH,
Hanover, Germany). RT-PCR was performed using Taq-
Man MGB gene expression assays and TaqMan Universal
PCR Master Mix on a 7900HT real-time PCR machine
(Applied Biosystems, Foster City, CA, USA). Gene expres-
sion was normalized to an endogenous reference gene 18S
rRNA (Hs99999901_s1; Applied Biosystems). AID-specific
primers and probe were designed using the online Universal
Probe Library Assay Design Centre (Roche Applied
Science, Penzberg, Germany). The primer/probe sets for
eGLT and cGLT were designed in-house, and the FAM-la-
beled MGB probes were purchased from Applied Biosys-
tems and corresponding forward and reverse primers
synthesized from Sigma-Aldrich Ltd. See Table S2 for infor-
mation about the primer/probe sets. SDS software was used
to determine relative quantification of the target cDNA
according to the 2(DDct) method.
Detection of Ie-Cl and Ie-Cc switch circle transcripts (SCTs)
CSR to IgE can be detected by the presence of SCTs, span-
ning from Ie to IgHM (Ie-Cl; SCT for direct switching from
IgM) or to IgHG (Ie-Cc; SCT for sequential switching
through an IgG intermediate) (25–27). Starting from the total
RNA, SCT cDNAs were amplified in a 20 ll nested PCR
using Phusion Flash High-Fidelity PCR Master Mix
(Thermo Scientific, Waltham, MA, USA), 1 ll cDNA, and
250 nM of forward or reverse primers (see Table S3 for
information about the primer sets; round 1: Ie Fw1 and Cl
Rev1 or Ie-Cl SCT and Cc Rev1; round 2: Ie Fw2 and Cl
Rev2 or Cc Rev2). Round 1 PCR were performed at 98°C
for 10 s, followed by 30 cycles of 98°C for 1 s, 68°C (Ie-Cc)
or 65°C (Ie-Cl) for 10 s and 72°C for 15 s, and 1 cycle at
72°C for 1 min. PCR2 was carried out at 98°C for 10 s, fol-
lowed by 20 cycles of 98°C for 1 s, 68°C (Ie-Cc) or 65°C (Ie-
Cl) for 5 s and 72°C for 15 s, and 1 cycle at 72°C for 1 min.
PCRs were standardized using equal amounts of RNA for
the cDNA synthesis. GAPDH was amplified to check the
integrity of cDNA. See Table S3 for information about the
primer/probe sets used.
Statistical analysis
Statistical analysis was performed using the one-way ANOVA,
with Bonferroni correction, or unless otherwise stated. A P
value of <0.05 was considered significant (*P < 0.05,
**P < 0.01, ***P < 0.001).
Results
Induction of CSR to IgE is highly variable in tonsil B-cell
cultures
To induce CSR to IgE, we cultured freshly isolated human
tonsil B cells with IL-4 and anti-CD40 antibody. We con-
firmed that our intracellular IgE staining correctly identifies
IgE+ cells in our cultures using an antibody against the long
form of membrane IgE (mIgEL), which recognizes an epitope
on the extramembrane proximal domain (EMPD) of mIgEL
that is absent from secreted IgE (28) (Fig. S1).
We found that the capacity of tonsil B cells to undergo
CSR to IgE in response to IL-4 and anti-CD40 is donor
dependent but independent of their reported allergic status.
The variation in CSR to IgE is exemplified by the FACS
plots from two typical tonsil B-cell cultures, one yielding a
‘low’ and the other a ‘high’ percentage of IgE+ B cells by
day 12 of the culture (Fig. 1A). The yields of IgE+ B cells
were more variable between tonsils than those of IgG+ B
cells (Fig. 1B). To gain an understanding of this variability,
we characterized the B-cell preparations giving rise to IgE+
cells that fell within the first quartile (low-switched) and the
third quartile (high-switched) of the distribution (Fig. 1B).
At the outset of cell cultures, we examined the percentages of
B cells expressing all five Ig classes and found there was no
variability, between the low-switched and high-switched cul-
tures, in the number of B cells expressing any of the Ig
classes (Fig. 1C). IgE+ cells were not detectable.
The frequency of eGC and memory B cells predicts the
capacity of tonsil B cells to undergo CSR to IgE
B cells in human lymphoid tissue are known to be hetero-
geneous in composition (19). Thus, we examined whether
A B C
Figure 1 Induction of CSR to IgE is highly variable in tonsil B-cell
cultures. (A) Intracellular staining of IgE and IgG on day 12 of a
total B-cell culture that yielded low levels (low-switched) and high
levels of IgE+ (high-switched) B cells. (B) IgE+ and IgG+ cell per-
centages on day 12 of culture. The dotted line on the IgE+ cell
graph indicates the first quartile (Q1 < 7%; low-switched) and the
third quartile (Q3 > 21%; high-switched). (C) FACS was used to
determine the starting frequencies of each Ig class in tonsil B cells
prior to culture. Data represent the mean of percentages  SD of
low-switched (n = 8) and high-switched (n = 8) B-cell cultures.
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the starting proportions of na€ıve, eGC, GC, and memory
B cells and plasmablasts (PBs) might correlate with the
yield of IgE+ B cells at the end of culture. Figure 2A and
B demonstrates that the frequency of eGC B cells was sig-
nificantly greater (P < 0.0001) and the frequency of mem-
ory B cells significantly lower (P < 0.0001) in the high-
switched compared to the low-switched cultures. The start-
ing frequencies of na€ıve and GC B cells and PBs were sim-
ilar between these cultures. Accordingly, the percentage of
IgE+ cells on day 12 of the culture was positively corre-
lated with the percentage of eGC B cells (r = 0.79,
P < 0.0001) and negatively correlated with the percentage
of memory B cells at the start of the culture (r = 0.73,
P < 0.0002) (Fig. 2C).
A
B
C
Figure 2 The starting frequency of eGC and memory B cells is
predictive of CSR to IgE. Surface staining of CD27 and CD38 on
purified tonsil B cells was used to assess the proportions of na€ıve,
eGC, GC, and memory B cells and plasmablasts at the outset of
culture. Representative FACS plots from low- and high-switched
cultures are shown in (A), and the data showing the mean (SD)
from low-switched (n = 8) and high-switched (n = 7) cell cultures
are summarized in (B). (C) Correlation of day 12 IgE+ cell percent-
ages with day 0 memory and eGC B-cell percentages. Correlation
analysis was performed using Spearman’s rank correlation coeffi-
cient (***P < 0.001).
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eGC and GC B cells exhibit the poorest survival but yield the
highest percentage of IgE+ cells
We next compared the capacity of na€ıve, eGC, GC, and
memory B cells to undergo CSR to IgE. The four B-cell sub-
sets were purified by FACS and cultured, alongside unfrac-
tionated total tonsil B cells, with IL-4 and anti-CD40
(Fig. S2). We observed that the cell viability was relatively
poor in the GC and eGC cultures, compared to the memory
and na€ıve B-cell cultures, with the unfractionated cells result-
ing in the expected intermediate yields (Fig. 3A). The
increased cell death in eGC and GC cells was directly pro-
portional to the expression levels of FAS (CD95) (Fig. 3B), a
marker associated with cell death (29).
Despite the relatively poor survival, the percentage of
IgE+ switched cells and the amounts of secreted IgE were
comparable between eGC and GC B-cell cultures but signifi-
cantly greater for the eGC compared to the na€ıve or the
memory B-cell cultures (Fig. 3C–E). In the case of the GC
cells, this difference did not reach significance, which may be
attributed to the higher rate of cell death compared to the
eGC cells (Fig. 3D and E). In contrast, the yields of IgG+ B
cells and secreted IgG were significantly higher in eGC, GC
and, notably, memory B cells compared to na€ıve B-cell cul-
tures (Fig. 3C–E), reflecting the high percentages of these
cells at the outset of the cell culture (Fig. S3).
Increased CSR to IgE is associated with increased cell
proliferation
CSR to IgE in IL-4- and anti-CD40-stimulated murine B
cells ex vivo depends on the number of cell divisions, with a
greater number of divisions required for IgE than for IgG
(30, 31). Therefore, we examined the proliferative capacity of
the high-switched and low-switched tonsil B cells, stained by
CSFE before culture, after 12 days of stimulation with IL-4
and anti-CD40. We observed that high-switched B-cell cul-
tures underwent robust proliferation, peaking at 6–7 cell divi-
sions, whereas the majority of the proliferating cells from the
low-switched B-cell culture had not undergone the same
number of divisions (Fig. 4A and B).
To pursue this further, we examined the proliferative
capacity of the FACS sorted na€ıve B cells, representing the
least productive tonsil B-cell fraction, and a mixture of eGC
and GC cells representing the more productive B-cell frac-
tions (Figs S4 and 4B). After 12 days of culture with IL-4
and anti-CD40, the IgE and CFSE FACS profiles indicated
that, unlike na€ıve B-cell cultures, the GC-derived B-cell cul-
tures had proliferated extensively and yielded a much higher
percentage of IgE+ cells (Fig. 4C and D).
eGC and GC B cells exhibit enhanced capacity for IL-4 and
anti-CD40 signaling
Given the important role of IL-4 and anti-CD40 in the
stimulation of CSR to IgE, we examined the capacity of
the different tonsil B-cell fractions to respond to these sig-
nals. Prior to culture with IL-4 and anti-CD40, the expres-
sion of the IL-4 receptor (IL-4R) and CD40 in eGC and
GC B cells was significantly higher than in na€ıve and
memory B cells (Fig. 5A). We also analyzed the phospho-
rylation of STAT6 and NFjB, two important downstream
signal transducers of IL-4R and CD40, respectively (22, 23,
32, 33), by FACS. Figure 5B demonstrates that the activity
A C
B D E
Figure 3 eGC and GC B-cell cultures yield the highest percentage
of IgE+ cells. (A) After 7 days in culture with IL-4 and anti-CD40,
we determined, using a live/dead fixable dead stain kit in combina-
tion with the side and forward side scatter gating, the cell viability
of the B-cell cultures. (B) Fold change of MFI of anti-FAS-stained
cells relative to na€ıve B cells. (C) FACS dot plots showing the intra-
cellular staining of IgE+ and IgG+ cells after 7 days of CSR culture.
(D) Percentage of IgE+ and IgG+ cells as determined by FACS anal-
ysis of the intracellularly stained day 7 na€ıve, memory, eGC, GC,
and total B-cell cultures. (E) IgE secretion and IgG secretion on day
7 of the cultures were analyzed by ELISA. Data represent the
mean  standard error of mean (SEM) and show the amounts of
secreted IgE and IgG [ng/ml] (*P < 0.05, **P < 0.01,
***P < 0.001).
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of these proteins reflects the relative levels of expression of
IL-4R and CD40.
To assess the outcome of these signaling pathways, we
used RT-PCR to measure the relative levels of expression of
eGLT (22, 34, 35) and AID (21). We also assayed cGLT to
see whether this differed between the B-cell fractions. The
expression levels of the AID mRNA, but not eGLT or
cGLT, were significantly upregulated in the GC and eGC
cells compared to the na€ıve and memory B cells (Fig. 5C).
To demonstrate unequivocally that IL-4 and anti-CD40
stimulates de novo CSR to IgE in vitro, we assayed switch cir-
cle transcripts (SCTs), transient by-products of CSR (25). We
assayed Ie-Cl and Ie-Cc PCR in na€ıve, memory, eGC, and
GC sorted B cells on days 0, 1, and 5 of the culture with IL-
4 and anti-CD40 using a nested PCR. Neither Ie-Cl nor Ie-
Cc transcripts could be detected in any of the fractions on
day 0 or day 1 (not shown), but they both appeared in all
four fractions by day 5 (Fig. 5D). These results demonstrate
that IL-4 and anti-CD40 stimulate both de novo direct
(IgM?IgE) and sequential (IgM?IgG?IgE) CSR to IgE in
the cultured tonsil B cells.
Discussion
IL-4 and anti-CD40 culture of tonsil B cells mimics the
conditions for the induction of CSR to IgE in vivo (5, 36).
In this study, we observed a wide variation in the yields of
IgE+ B cells in IL-4 and anti-CD40 cultures of tonsil B
cells from different donors. The yields of IgE+ cells at day
12 of the cultures were negatively correlated with the pro-
portion of memory B cells and positively correlated with
the proportion of eGC B cells at the outset of the cell cul-
ture. This can be rationalized by the intrinsic properties of
these cells, namely the relative strength of the response to
IL-4 and anti-CD40 signaling and the differing rates of cell
proliferation.
A B
C D
Figure 4 The yields of IgE+ cells in IL-4 and anti-CD40 cultures are
associated with the proliferative capacity of the cultured cells. (A)
Division of cells from a representative low-switched and high-
switched tonsil B-cell culture as determined by the CFSE dilution,
whereby each peak, as indicated by the numbers, represents suc-
cessive cell divisions. Data are derived from the results on day 12 of
cell culture and are representative of three experiments. (B) Percent-
age of cells at each divisional peak in the low- and high-switched ton-
sil B-cell cultures. Data are derived from the results on day 12 of cell
culture and represent the mean of percentages  SD of low-
switched (n = 3) and high-switched (n = 3) B-cell cultures. (C) FACS
plots show the proliferative capacity of the sorted na€ıve and total GC
(eGC and GC) B cells, as determined by the CFSE dilution, and the
percentage of IgE+ cells, as determined by intracellular staining, on
day 12 of the IL-4 and anti-CD40 cultures. (D) The summarized per-
centage of proliferating cells in the na€ıve and eGC/GC B-cell cultures.
Data are derived from the results on day 12 of cell culture and repre-
sent the mean of percentages  SD of na€ıve (n = 4) and eGC/GC
(n = 4) B-cell cultures. Statistical analysis was performed using an
unpaired two-tailed t-test (*P < 0.05, **P < 0.01).
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Prior to culture with IL-4 and anti-CD40, eGC and GC B
cells already exhibit upregulated IL-4R and CD40 expression.
These expression levels, upon stimulation, were reflected on
their activation of critical signal transduction factors, STAT6
and NFjB, and AID mRNA, which together are required
for CSR to IgE, giving eGC and GC B cells a ‘head start’
over the other B-cell fractions. STAT6 and NFjB bind
directly to the e germline gene to activate transcription (22,
34, 35). The resulting transcription is involved in remodeling
the chromatin in the region of the gene to make it accessible
for subsequent recombination, and the transcript itself partic-
ipates in the mechanism of CSR (37).
CSR to IgE depends on the number of cell divisions and
requires a greater number for IgE compared to IgG (30, 31),
suggesting that another important factor contributing to the
observed differences in the yields of IgE+ cells is the prolifer-
ative capacity of the cultured cells. Our data clearly demon-
strate that tonsil B-cell cultures that yield high percentages of
IgE+ cells and specifically cells from the GC compartments
undergo robust proliferation. We cannot exclude the possibil-
ity of an antigen driving the proliferation of the switching B
cells in our high-switched cultures and contributing to the
higher yields of IgE+ cells. However, it is unlikely to occur
via BCR cross-linking ex vivo, as this inhibits CSR to IgE
(38, 39).
It is well documented that B cells within GCs proliferate
very robustly and undergo SHM and recombination specifi-
cally (with rare exceptions) in Ig genes, a mechanism that has
evolved to diversify the antibody repertoire prior to affinity
maturation in the immune response (10, 14, 40). These pro-
cesses are known to predispose B cells to apoptosis, indicated
here by the high rates of cell death in eGC B-cell cultures and
even higher rates of cell death in GC B-cell cultures. Activated
B cells are known to express Fas ligand (41), and the interac-
tion of Fas with its ligand has been implicated during the nega-
tive selection of B cells in the GCs (42, 43). The differential
expression of Fas by eGC and GC B cells, although it may not
be a specific mechanism that fully accounts for cell death in B
cells from the GC compartments, may explain the differing
rates of cells death in these cultures. Therefore, considering
that eGC and GC B-cell cultures yield comparable percentages
of IgE+ cells, the differences in the cell viability of these B cells
A
C D
B
Figure 5 Enhanced IL-4R and CD40 signaling in eGC and GC B
cells. (A) IL-4R and CD40 expression levels on tonsil B cells prior to
culture with IL-4 and anti-CD40. Data show the percentage change
in MFI of anti-IL-4R- and anti-CD40-stained cells relative to na€ıve B
cells. (B) STAT6 and NFjB phosphorylation levels 24 h poststimula-
tion with IL-4 and anti-CD40. Data show the fold change in MFI of
anti-p-STAT6 (Tyr641)- and anti-p-NFjB p65 (Ser536)-stained cells
relative to na€ıve B cells. They represent the mean  SD and are
derived from three different tonsils. (C) RT-PCR analysis of AID,
eGLT, and cGLT expression 24 h poststimulation with IL-4 and anti-
CD40. Data represent the mean  SD of the relative quantification
(RQ) and are derived from three different tonsils. (D) RNA was
isolated from the sorted na€ıve, memory, eGC, and GC B cells on
day 0 (preculture) and day 5 of cell culture with IL-4 and anti-CD40
antibody, The presence of Ie-Cl SCTs (167 bp; direct switching)
and Ie-Cc SCTs (202 bp; sequential switching) was determined by
nested PCR. Because of the nature of the nested PCR, the inten-
sity of the PCR band does not necessarily reflect the amounts of
switching occurring in our cultures. The positive control was cDNA
from an IL-4- and anti-CD40-stimulated tonsil B-cell culture that
yielded high percentages of IgE+ cells. The negative control was
distilled H2O. Data are representative of three experiments.
M = size marker, and bp = the size of the cDNA in base pairs
(*P < 0.05, **P < 0.01, ***P < 0.001).
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might explain why a tonsil B-cell culture starting with a higher
proportion of eGC B cells would yield more IgE+ B cells.
We were unable to detect IgE+ cells in tonsil B cell at the
outset of the cultures, and we only see IgE+ cells after 3–
4 days in IL-4 and anti-CD40 cultures, approximately the
time when we can also detect e circle transcripts and other
markers of CSR to IgE (P. Hobson and D. Fear, unpub-
lished). SCT analysis demonstrated de novo CSR from IgG
as well as from IgM in our B-cell cultures. The IgG+ B-cell
precursors may have been ones that were already present at
the outset of the cultures, or ones that resulted by de novo
switching from IgM to IgG en route to IgE ex vivo.
Although there may be a higher frequency of CSR to IgG
than to IgE (44, 45), we observed that the mean yield of IgG
cells is similar to that of IgE. This probably reflects the
onward switching from IgG to IgE. The dynamic interplay
between SHM and CSR from the different isotypes to IgE is
a problem that can be tackled in future studies with this
ex vivo system.
After CSR, the B cells must undergo plasma cell differenti-
ation to secrete IgE. This evidently occurs in our cultures, as
indicated by the secretion of IgE. Indeed, in our FACS pro-
files we observe two IgE+ cell populations (Fig. 1A), which
are reminiscent of the two IgE+ cell populations observed in
mice (18), and we have characterized these cells as plasma
cell precursors in our ongoing work.
Understanding the mechanisms of CSR to IgE is essential
for a full understanding of the pathophysiology of allergic
disease. Our findings open up new avenues of research on
human B cells to validate the conclusions from mouse models
of this disease or discover inherent differences between the
two species to account for the higher risk of developing aller-
gic disease in humans (3).
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